Reprise Biomedical

Reprise Biomedical

Biotechnology, Medina Rd Ste 100, Plymouth, , 55447, Minnesota, 17400, United States, 11-50 Employees

reprisebio.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 95********

Who is REPRISE BIOMEDICAL

Reprise Biomedical, Inc. is focused on the development and commercialization of biological medical devices which offer advanced solutions for healing. Reprise was established as a spin-of...

Read More

map
  • 17400 Medina Rd Ste 100, Plymouth, Minnesota, 55447, United States Headquarters: 17400 Medina Rd Ste 100, Plymouth, Minnesota, 55447, United States
  • 2019 Date Founded: 2019
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $5 Million to $10 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 3841 | NAICS Code: 339112 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from REPRISE BIOMEDICAL

Reprise Biomedical Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Reprise Biomedical

Answer: Reprise Biomedical's headquarters are located at Medina Rd Ste 100, Plymouth, , 55447, Minnesota, 17400, United States

Answer: Reprise Biomedical's phone number is 95********

Answer: Reprise Biomedical's official website is https://reprisebio.com

Answer: Reprise Biomedical's revenue is $5 Million to $10 Million

Answer: Reprise Biomedical's SIC: 3841

Answer: Reprise Biomedical's NAICS: 339112

Answer: Reprise Biomedical has 11-50 employees

Answer: Reprise Biomedical is in Biotechnology

Answer: Reprise Biomedical contact info: Phone number: 95******** Website: https://reprisebio.com

Answer: Reprise Biomedical, Inc. is focused on the development and commercialization of biological medical devices which offer advanced solutions for healing. Reprise was established as a spin-off from Miromatrix Medical Inc. in July 2019 and took ownership of the manufacturing, marketing, and distribution for two commercially available products, MiroDerm biologic wound matrix and MiroFlex biologic matrix for soft tissue reinforcement. The company is committed to innovation using our proprietary perfusion decellularization technology to develop new medical devices which address unmet surgical needs for healing. Our newest product, Miro3D wound matrix, is an example of that commitment. Miro3D broadens our wound management portfolio by offering a unique three-dimensional solution for deep and tunneling wounds.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access